Sarepta Therapeutics Tumbles 30% After Delay Of Eteplirsen Approval
Article By:
Terry Chrisomalis
Read
Monday, October 27, 2014 5:17 PM EDT
Though results were positive, FDA determines that eteplirsen study was too small and asks for more data.
In this article: SRPT
Allergan Beats On Earnings, Revenues; Valeant Raises Offer
Article By:
Zacks Investment Research
Read
Monday, October 27, 2014 8:29 AM EDT
Allergan’s presence across different segments will help maintain growth.
5 Stocks To Watch This Week 10/26/14
Article By:
Leigh Drogen
Read
Sunday, October 26, 2014 7:55 PM EDT
We’ve got a huge week ahead for social media stocks. Over the next 5 days we will be getting earnings releases from Twitter (TWTR), Facebook (FB), and LinkedIn (LNKD). Other highly anticipated reports will be coming from Hepatitis C drugmaker Gilead Sciences (GILD) and travel site Expedia (EXPE).
Corporate Vs. Non-Corporate Partnerships, Joint Ventures, Merger And Acquisitions, And MannKind’s Affairs
Article By:
Retail Investor 360
Read
Sunday, October 26, 2014 6:13 PM EDT
The market has been speculating as to whether the MannKind-Sanofi partnership will lead to a full-blown merger and acquisition.
Cops Exit Ebola Victim Apartment And Throw Paraphernalia In Sidewalk Trash - Big Fail
Article By:
TalkMarkets DailyTalk
Read
Saturday, October 25, 2014 3:41 PM EDT
Often our attitudes towards protecting ourselves and others from infectious diseases are too cavalier, possibly because it has been a long time since we've been truly frightened about a raging epidemic.
How To Hide Orders And Get Trade Rebates
Article By:
ProTraderMike
Read
Saturday, October 25, 2014 1:54 PM EDT
This video from MojoTrading.com demonstrates how you can hide order size & get rebates in the Level 2.
Regulus Therapeutics Continues Its Uptrend After Positive Data In Early Hepatitis C Study
Article By:
Terry Chrisomalis
Read
Friday, October 24, 2014 2:19 PM EDT
Shares of Regulus Therapeutics (RGLS) soared as much as 100% in one trading session after the company released some early data for their Hepatitis C drug.
In this article: RGLS
Bill Ackman's Big Pharma Trade: The Drama Doesn't Stop
Article By:
TalkMarkets DailyTalk
Read
Friday, October 24, 2014 1:31 PM EDT
If you're following Valeant's proposed takeover (or merger) of Allergan and the lawsuit by Allergan against Valeant and notorious hedge fund manager William Ackman for insider trading, this is a must-read article.
SBOTF And BVTI Sign KLH Supply Agreement For BiovaxID Immunotherapy
Article By:
BioMedReports
Read
Friday, October 24, 2014 4:27 AM EDT
SBOTF and BTVI announced the companies have executed a definitive supply agreement to meet Biovest's requirements for Keyhole Limpet Hemocyanin for use in Biovest's BiovaxID® active immunotherapy
